ABC Arbitrage was informed by letter on November 24, 2021 of the sale of all ABC arbitrage securities held by IPA on November 22, 2021. These securities (367,763 shares) were sold to the company Financière WDD through a block transaction at market price, ie 7.085 euros. The acquisition of all ABC Arbitrage securities held by IPA by WDD Financial has in practice no impact on the capital allocation of ABC Arbitrage, the investment company said.
Carbios, alongside its partners T.EN Zimmer GmbH and Deloitte, obtained European funding of 3.3 million euros (including 3 million euros for Carbios) in the form of a subsidy. T.EN Zimmer GmbH brings its expertise on the repolymerization of 100% recycled PET monomers and Deloitte on the analysis of the environmental performance (in particular via the Life Cycle Analysis) of the process from plastic and textile waste.
Gaussin announced an exclusive 20-year production and licensing agreement with Nexport, an Australian producer and supplier of electric vehicles. This contract follows the signing of the modalities agreement last September. The 20-year joint venture and license agreement provides for the assembly and local supply of Gaussin’s range of zero-emission vehicles and systems for port terminals, airports, logistics and passenger transport applications.
The champagne house will publish its half-year results.
Quantum Genomics announced the signing of an exclusive license agreement with Teva Israel Ltd. – subsidiary of Teva Pharmaceutical Industries Ltd – to market firibastat in Israel. Teva will receive exclusive marketing rights for its historic market in the resistant and difficult-to-treat hypertension indication. The French biopharmaceutical company will receive payments of up to $ 11 million as well as royalties ranging from 25% up to 30% on future sales of firibastat.
The AOF information reproduced on Capital.fr is taken from the AOF information service. This information is protected by intellectual property rights owned by OPTION FINANCE SAS, publisher of the AOF real-time stock market information service, and its contributors. Consequently, any reproduction, copy, duplication, modification, transfer, redistribution, translation, commercial or non-commercial exploitation, creation of hypertext link or reuse in any way whatsoever of this information is subject to the prior written agreement of OPTION. FINANCE SAS and its contributors. AOF can be reached at the following address [email protected] OPTION FINANCE SAS collects its data from sources it considers the most reliable. However, subject to gross negligence, OPTION FINANCES SAS and its contributors in no way guarantee the absence of errors and defects, even hidden, nor the exhaustiveness or lack of conformity for any use whatsoever of these data and of OPTION FINANCE. SAS or one of its contributors, and cannot be held responsible for delays or interruptions that could affect access to them. The user of the OPTION FINANCE SAS service will use AOF data at his own risk and must hold OPTION FINANCE SAS and its contributors harmless from any claim resulting from this use.
Receive our latest news
Every morning, the information to remember about financial markets.